VRTX- Vertex Pharmaceuticals Incorporated

Name: Vertex Pharmaceuticals Incorporated Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kewalramani Reshma	133.5K	$59.39M	-
COO	Arbuckle Stuart A	63.4K	$28.19M	-
VP	Wagner Charles F Jr	51.1K	$22.73M	-
VP	Tatsis Ourania	42.3K	$18.82M	-
Other	Leiden Jeffrey M	24.0K	$10.69M	-

Activity

Buys and sells only

Transactions

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 30, 2023	Arbuckle Stuart A	EVP, COO	Sell	82	$329.82	$27,045.24	-0.1%	+8.1%	+35.6%
May 30, 2023	Ambrose Kristen	SVP &Chief Accounting Officer	Sell	289	$329.82	$95,317.98	-4.1%	+8.1%	+35.6%
May 8, 2023	Sanna Bastiano	EVP, Cell &Genetic Therapies	Sell	3,272	$350.00	$1,145,212.66	-4.7%	+0.4%	+19.2%
May 8, 2023	Leiden Jeffrey M47	Executive Chairman	Sell	2,004	$349.25	$699,887.34	-1.8%	+0.4%	+19.2%
May 3, 2023	Sanna Bastiano	EVP, Cell &Genetic Therapies	Sell	4,403	$350.71	$1,544,186.50	-2.3%	+0.4%	+15.5%
May 3, 2023	Leiden Jeffrey M47	Executive Chairman	Sell	10,958	$349.98	$3,835,061.76	-4.3%	+0.4%	+15.5%
May 2, 2023	Bhatia Sangeeta N.48	Director	Sell	580	$348.28	$202,003.80	-2.3%	+1.8%	+16.2%
Apr 27, 2023	Kewalramani Reshma55	CEO &President	Sell	3,317	$339.08	$1,124,726.05	-0.9%	+3.7%	+17.1%
Apr 12, 2023	Sanna Bastiano	EVP, Cell &Genetic Therapies	Sell	7,567	$326.70	$2,472,164.15	-5.6%	+4.7%	+22.6%
Apr 12, 2023	Sachs Bruce I51	Director	Sale+OE	21,300	$326.73	$6,959,421.75	-12.4%	+4.7%	+22.6%

← PrevPage 13Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC